2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

Overview

NA

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Caio Max Rocha-Lima, MD, MS

Date of Release

June 23rd, 2025